about
Genome-wide association study of vitamin B6, vitamin B12, folate, and homocysteine blood concentrationsUsefulness of aspirin resistance after percutaneous coronary intervention for acute myocardial infarction in predicting one-year major adverse coronary eventsRole of glycoprotein Ia gene polymorphisms in determining platelet function in myocardial infarction patients undergoing percutaneous coronary intervention on dual antiplatelet treatmentResidual platelet reactivity is associated with clinical and laboratory characteristics in patients with ischemic heart disease undergoing PCI on dual antiplatelet therapyImpact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosisComparison of different methods to evaluate the effect of aspirin on platelet function in high-risk patients with ischemic heart disease receiving dual antiplatelet treatmentOxidative modification of fibrinogen is associated with altered function and structure in the subacute phase of myocardial infarction.Role of C677T and A1298C MTHFR, A2756G MTR and -786 C/T eNOS gene polymorphisms in atrial fibrillation susceptibility.High sensitivity C-reactive protein predicts the development of new carotid artery plaques in older personsCharacterization of Khorasan wheat (Kamut) and impact of a replacement diet on cardiovascular risk factors: cross-over dietary intervention studyInflammatory and antioxidant pattern unbalance in "clopidogrel-resistant" patients during acute coronary syndromeEffect of Triticum turgidum subsp. turanicum wheat on irritable bowel syndrome: a double-blinded randomised dietary intervention trial.Unbalanced Metalloproteinase-9 and Tissue Inhibitors of Metalloproteinases Ratios Predict Hemorrhagic Transformation of Lesion in Ischemic Stroke Patients Treated with Thrombolysis: Results from the MAGIC Study.PAI-1 and homocysteine, but not lipoprotein (a) and thrombophilic polymorphisms, are independently associated with the occurrence of major adverse cardiac events after successful coronary stentingVitamin B12 and homocysteine levels and 6-year change in peripheral nerve function and neurological signs.Risk and Determinants of Dementia in Patients with Mild Cognitive Impairment and Brain Subcortical Vascular Changes: A Study of Clinical, Neuroimaging, and Biological Markers-The VMCI-Tuscany Study: Rationale, Design, and Methodology.Association between homocysteine, vitamin B(6) concentrations and inflammation.Residual platelet reactivity on aspirin therapy and recurrent cardiovascular events--a meta-analysis.Relation of CYP2C19 loss-of-function polymorphism to the occurrence of stent thrombosis.Cytochrome P450 2C19*2 polymorphism and cardiovascular recurrences in patients taking clopidogrel: a meta-analysis.Thrombosis and acute coronary syndrome.High residual platelet reactivity after clopidogrel loading and long-term cardiovascular events among patients with acute coronary syndromes undergoing PCI.Feasibility and relevance of right parasternal view for assessing severity and rate of progression of aortic valve stenosis in primary care.The Mugello study, a survey of nonagenarians living in Tuscany: design, methods and participants' general characteristics.Relation of cytochrome P450 2C19 loss-of-function polymorphism to occurrence of drug-eluting coronary stent thrombosis.Relationship among endothelial response to hyperemia, bone marrow-derived progenitor cells, and parathyroid hormone in renal transplantation.Cytochrome P450 2C19 loss-of-function polymorphism, but not CYP3A4 IVS10 + 12G/A and P2Y12 T744C polymorphisms, is associated with response variability to dual antiplatelet treatment in high-risk vascular patients.A time course study of high on treatment platelet reactivity in acute coronary syndrome male patients on dual antiplatelet therapy.High-throughput multiplex single-nucleotide polymorphism (SNP) analysis in genes involved in methionine metabolism.Impact of a cardiac rehabilitation program and inflammatory state on endothelial progenitor cells in acute coronary syndrome patients.n-3 PUFA supplementation, monocyte PCA expression and interleukin-6 production.Reticulated platelets and platelet reactivity in renal transplant recipients receiving antiplatelet therapy.Anti-inflammatory effects of low molecular weight heparin derivative in a rat model of carrageenan-induced pleurisy.eNOS gene influences platelet phenotype in acute coronary syndrome patients on dual antiplatelet treatment.Global platelet hyperreactivity and elevated C-reactive protein levels predict long term mortality in STEMI patients.Tissue factor and tissue factor pathway inhibitor levels in unstable angina patients during short-term low-molecular-weight heparin administration.Hypercoagulability, high tissue factor and low tissue factor pathway inhibitor levels in severe ovarian hyperstimulation syndrome: possible association with clinical outcome.Increased plasma levels of lipoprotein(a) and the risk of idiopathic and recurrent venous thromboembolism.Cytokine gene expression and production by human LPS-stimulated mononuclear cells are inhibited by sulfated heparin-like semi-synthetic derivatives.Cyclooxygenase and lipoxygenase metabolite synthesis by polymorphonuclear neutrophils: in vitro effect of dipyrone.
P50
Q24644637-8D6B0B1C-1539-44FD-9E9A-F6F76C68FCFFQ28200883-3DC587D4-A338-4995-87AF-BAE245445B51Q28212216-4DE3F033-B6B0-4F54-8A81-F806AC7B3FCDQ28212833-00945E3D-B1A8-4FF1-A96F-8C5BA3FE058EQ28213327-92D199EB-C00F-497B-B090-833A36548FC2Q28213687-18C7C6A9-B312-4959-98B8-9176F2C3C7D8Q30362121-99960171-E002-41B1-91AE-484032868057Q33286816-48478DA6-4A57-4315-83E7-8BDB0C9ADC49Q34138655-45A49BDC-D51B-48BD-872B-2A47E76E0207Q34658745-E122A1B9-7B45-42BB-8F7F-EDFC02515962Q35250401-0CC98E1D-527F-44D1-AE9C-A12A365CC8EDQ35517355-9D06DDAE-2652-434A-B9CE-4AF9D6FE018EQ35652269-F99D974F-94E8-4ECB-8BEA-34EB6AA65A18Q35771481-99C5C69D-F813-43CC-AB55-57FF17ACA338Q35888602-004910D4-049D-44B3-BB09-709EF1F7F453Q35895842-2E86175C-B1FB-4611-A3D9-F4393DA0C8A8Q36996487-7AFD889B-576E-426A-A4B2-5D69B0C6271EQ37074802-2B854D95-1540-4C2D-8B90-B1D1A7464E2BQ37693951-DB1E6603-CBAD-4380-A45C-8E99E960C626Q37721156-9EA6AFC7-A0FF-4D1F-A22F-B63A474DDF2CQ37979021-AD4025AE-3507-48E7-A82B-C74E74EE9985Q38484239-E0367D9B-198F-43B1-855C-655F559369E9Q38788821-3CF1BD92-CC53-45D3-9D95-DB8FFF7690ACQ39332850-BE169D11-2278-4305-A90A-946FD58AE0DFQ39996910-92F99025-B093-45AD-9E54-3D91FE1B9C1EQ40021946-A5FCB2DF-9CEF-4A99-8E4C-2A20DBDCD4BCQ40154187-9B62E253-1701-4A20-87CD-A572E6552D68Q40719450-FFC46A70-DB8E-487D-9600-F4AAC6B9106BQ42167125-566A7F2B-4E5D-411F-A126-FC63A9C459F9Q42506943-5336B03D-D538-4EBD-8C06-E64B43FC5386Q42526046-F858D15A-87BB-435F-8997-6DC62F126A74Q43037614-3E0427AE-876C-418C-AE33-5965CC910363Q43168766-2943F524-7DF0-4B93-A875-EA0932D9E942Q43248056-70C68045-66CC-4B9F-A41A-2F74279A13DFQ43498973-F5FF9814-748E-4823-A2B9-933E6F699D8AQ44004556-21220CD6-261A-4FE6-BCF5-5ADBA40F5A8FQ44403821-6C5757EF-BBF0-44F4-BAC4-08E869B20BEEQ44680678-9C5DD83C-FA15-497B-BD0A-3CAD7B1F4767Q45033743-BE70EC51-DA98-4858-82CB-2601518191E6Q45045732-B7720FCF-108A-424C-8746-D28453578952
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Anna Maria Gori
@ast
Anna Maria Gori
@en
Anna Maria Gori
@es
Anna Maria Gori
@nl
type
label
Anna Maria Gori
@ast
Anna Maria Gori
@en
Anna Maria Gori
@es
Anna Maria Gori
@nl
prefLabel
Anna Maria Gori
@ast
Anna Maria Gori
@en
Anna Maria Gori
@es
Anna Maria Gori
@nl
P1053
K-6077-2016
P106
P1153
7005319380
P21
P31
P3829
P496
0000-0001-6857-5861